United States · FDA National Drug Code directory

GABAPENTIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2521_9e261ec8-4838-464b-a004-0f9ce246c760
Product NDC
71335-2521
Form
CAPSULE
Composition / generic term
gabapentin
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20210510
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 20 CAPSULE in 1 BOTTLE (71335-2521-0) · 71335-2521-0
  • 30 CAPSULE in 1 BOTTLE (71335-2521-1) · 71335-2521-1
  • 90 CAPSULE in 1 BOTTLE (71335-2521-2) · 71335-2521-2
  • 60 CAPSULE in 1 BOTTLE (71335-2521-3) · 71335-2521-3
  • 120 CAPSULE in 1 BOTTLE (71335-2521-4) · 71335-2521-4
  • 100 CAPSULE in 1 BOTTLE (71335-2521-5) · 71335-2521-5
  • 28 CAPSULE in 1 BOTTLE (71335-2521-6) · 71335-2521-6
  • 112 CAPSULE in 1 BOTTLE (71335-2521-7) · 71335-2521-7
  • 84 CAPSULE in 1 BOTTLE (71335-2521-8) · 71335-2521-8
  • 180 CAPSULE in 1 BOTTLE (71335-2521-9) · 71335-2521-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →